Eledon Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ELDN
Share price (3/24/26): $2.89
Market cap (3/24/26): $219 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1 2025 – amended

ended 12/31/24 FY 2024 – amended

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Ra Capital Management, L.P.

Coastlands Capital LP

McBride John S.

News Filter

Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Announces Recent Business Highlights and Third Quarter 2025 Financial Results

Material Definitive Agreement, Financial Statements or Exhibits

Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness